Life Sciences Tools & Services
Price
$1308.43
+0.62%Market Cap
$26.44B
Day High
$1321.47
Day Low
$1291.68
Mettler-Toledo (MTD) delivered solid Q1 2026 results with revenue up 7.2% YoY to $947.1M and EPS (diluted) up 6.7% to $8.33, though operating cash flow declined 28.1% and the company carries negative stockholders' equity due to its aggressive share buyback program.
Key risk: Negative Stockholders' Equity
MTD's stockholders' equity stands at -$41.9M as of Q1 2026, a structural feature driven by cumulative share repurchases exceeding retained earnings. While improving from -$182.0M a year ago, this balance sheet structure means the company is technically insolvent on a book-value basis and relies heavily on continued strong cash generation to service its obligations.
Other Life Sciences Tools & Services companies